Sign in

CIK 0001087294

  • Non-accelerated filer
  • Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
Operating
EIN
621765329
Phone
+1 615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
  1. 4 Grant or award Director acquired 1,000 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market buy Chief Financial Officer bought 400 shares at an average $6.00 ($2,400)
  4. 4 Gift Chairman and CEO gave 200,000 shares (gift)
  5. 4 Open-market buy Chief Financial Officer bought 400 shares at $6.12 ($2,448)
  6. 4 Grant or award Sr VP/Chief Commercial Officer acquired 5,000 shares (grant or award)
  7. 4 Grant or award SVP and Chief Development Off. acquired 25,000 shares (grant or award)
  8. 4 Grant or award VP and Chief Compliance Office acquired 3,000 shares (grant or award)
  9. 4 Grant or award Chairman and CEO acquired 100,000 shares (grant or award)
  10. 4 Grant or award Director acquired 1,000 shares (grant or award)
  11. 4 Grant or award Director acquired 1,000 shares (grant or award)
  12. 4 Grant or award Director acquired 1,000 shares (grant or award)
  13. 4 Grant or award Director acquired 1,000 shares (grant or award)
  14. 4 Grant or award Director acquired 1,000 shares (grant or award)
  15. 4 Grant or award Director acquired 5,000 shares (grant or award)
  16. 4 Open-market buy Chief Financial Officer bought 300 shares at $6.72 ($2,016)
  17. 4 Gift Chairman and CEO gave 15,000 shares (gift)
  18. 4 Open-market buy Director bought 3,300 shares at $7.55 ($24,915)
  19. 4 Open-market buy Chief Financial Officer bought 250 shares at $7.81 ($1,953)
  20. 4 Open-market buy Chief Financial Officer bought 500 shares at $6.72 ($3,360)

Page 17 of 26 · 512 filings